11/11/2024
|
07:00
|
Institutional Investment
|
RNS
|
30/10/2024
|
07:00
|
Schedule for Phase I Clinical Trial Opening
|
RNS
|
02/10/2024
|
11:19
|
Strategic Investment from Prevail Partners, LLC
|
RNS
|
27/09/2024
|
07:00
|
Half-year Report
|
RNS
|
09/09/2024
|
07:00
|
FLT3 Assay Ready for Phase I Trials at MD Anderson
|
RNS
|
02/09/2024
|
07:00
|
CDX Development Update
|
RNS
|
28/08/2024
|
07:00
|
Presentation at CBD S&T Conference
|
RNS
|
27/06/2024
|
16:39
|
Result of Annual General Meeting
|
RNS
|
17/06/2024
|
07:00
|
Operations Update
|
RNS
|
03/06/2024
|
07:00
|
Posting of Annual Report & Notice of AGM
|
RNS
|
25/04/2024
|
07:00
|
Final Results
|
RNS
|
28/03/2024
|
07:00
|
Total Voting Rights
|
RNS
|
29/02/2024
|
07:00
|
Placing to Raise US$4.2 million
|
RNS
|
16/02/2024
|
07:00
|
CBR Brain Delivery
|
RNS
|
14/02/2024
|
07:00
|
CBR Intranasal Delivery
|
RNS
|
09/02/2024
|
07:00
|
FDA Consents to Phase I Trials of HEMO-CAR-T
|
RNS
|
02/02/2024
|
07:00
|
Approval and Issuance of U.S. Conditioning Patent
|
RNS
|
16/01/2024
|
07:00
|
Submission of Complete Response to Clinical Hold
|
RNS
|
08/01/2024
|
07:00
|
HEMO-CAR-T Process Qualification Run Completed
|
RNS
|
28/11/2023
|
12:19
|
Placing to Raise £534,375
|
RNS
|
27/11/2023
|
07:00
|
CBR Expanded to Treatment of Cancer
|
RNS
|
15/11/2023
|
07:00
|
Lentivirus Re-manufacturing Completed
|
RNS
|
31/10/2023
|
07:00
|
Total Voting Rights
|
RNS
|
28/09/2023
|
12:28
|
Half-year Report
|
RNS
|
18/09/2023
|
07:00
|
Strategic Investment from Prevail Partners, LLC
|
RNS
|
14/09/2023
|
07:00
|
Clinical Hold Lift Plan is accepted by FDA
|
RNS
|
10/07/2023
|
07:00
|
Full FDA Review for HEMO-CAR-T IND
|
RNS
|
30/06/2023
|
16:07
|
Result of Annual General Meeting
|
RNS
|
02/06/2023
|
14:01
|
Posting of Annual Report & Notice of AGM
|
RNS
|
02/06/2023
|
11:24
|
Clinical Hold on IND for HEMO-CAR-T
|
RNS
|
09/05/2023
|
07:00
|
Submission of IND for HEMO-CAR-T
|
RNS
|
28/04/2023
|
10:05
|
Equity Incentive Pool Increase and Option Grant
|
RNS
|
28/04/2023
|
07:00
|
Final Results for the Year Ended 31 December 2022
|
RNS
|
28/02/2023
|
07:00
|
Total Voting Rights
|
RNS
|
07/02/2023
|
14:30
|
Admission of Shares to Official List
|
RNS
|
26/01/2023
|
09:05
|
Second Price Monitoring Extn
|
RNS
|
26/01/2023
|
09:00
|
Price Monitoring Extension
|
RNS
|
26/01/2023
|
07:00
|
Placing to Raise £4,056,250
|
RNS
|
16/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
16/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
13/01/2023
|
11:05
|
Second Price Monitoring Extn
|
RNS
|
13/01/2023
|
11:00
|
Price Monitoring Extension
|
RNS
|
12/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
12/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
12/01/2023
|
14:05
|
Second Price Monitoring Extn
|
RNS
|
12/01/2023
|
14:00
|
Price Monitoring Extension
|
RNS
|
10/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
09/01/2023
|
09:05
|
Second Price Monitoring Extn
|
RNS
|
09/01/2023
|
09:00
|
Price Monitoring Extension
|
RNS
|
05/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|